Bayer must convince NICE it has not overestimated the effectiveness of Xarelto
10 January 2012
Francesca Bruce
Please Login to read the full article.
10 January 2012
Francesca Bruce
Please Login to read the full article.
RELATED CONTENT
NEWS
- Pradaxa finally wins English warfarin replacement race, despite appeal
- Boehringer Ingelheim convinces NICE that Pradaxa is cost-effective
- NICE needs more info on Pradaxa before it can win warfarin replacement race
- BMS/Pfizer's Eliquis better than Lovenox, but comparison with Pradaxa and Xarelto not clear, says NICE
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
